Inventor · disambiguated record
Catalin Nistor
Also filed as: NISTOR CATALIN
13 granted patents·15 pending applications·65 citations·filing 2007–2025
90Inventor score
Top patents by PatentIndex Score
28 records- 0195US11135264B2Formulations containing a somatostatin receptor agonistCAMURUS AB·Filed 2020·Granted Oct 5, 2021·3 cites·32 claims
- 0295US8097239B2Controlled-release formulationsJOHNSSON MARKUS·Filed 2007·Granted Jan 17, 2012·42 cites·6 claims
- 0394US10688148B2Formulations containing a somatostatin receptor agonistCAMURUS AB·Filed 2019·Granted Jun 23, 2020·7 cites·49 claims
- 0490US11564968B2Formulations containing a somatostatin receptor agonistCAMURUS AB·Filed 2021·Granted Jan 31, 2023·1 cites·31 claims
- 0586US2025000982A1Peptide slow-release formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 0685US11241476B2Mixtures and formulations comprising an alkyl ammonium EDTA saltCAMURUS AB·Filed 2017·Granted Feb 8, 2022·1 cites·24 claims
- 0784US9668967B2Lipid formulations comprising a thiolated antioxidantNISTOR CATALIN·Filed 2009·Granted Jun 6, 2017·3 cites·13 claims
- 0883US9974861B2Peptide slow-release formulationsJOHNSSON MARKUS·Filed 2008·Granted May 22, 2018·4 cites·21 claims
- 0982US9820934B2Acid containing lipid formulationsNISTOR CATALIN·Filed 2008·Granted Nov 21, 2017·2 cites·25 claims
- 1081US2025319097A1Prostacyclin analogue formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 1181US2025121035A1Controlled release peptide formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 1280US12257282B2Mixtures and formulationsCAMURUS AB·Filed 2022·Granted Mar 25, 2025·0 cites·38 claims
- 1379US11672843B2Somatostatin receptor agonist formulationsCAMURUS AB·Filed 2013·Granted Jun 13, 2023·1 cites·29 claims
- 1477US2023372436A1Somatostatin receptor agonist formulationsCAMURUS AB·Filed 2023·Application pending·0 cites
- 1576US2025345385A1Mixtures and formulations comprising an alkyl ammonium edta saltCAMURUS AB·Filed 2025·Application pending·0 cites
- 1673US2021268112A1Peptide slow-release formulationsCAMURUS AB·Filed 2021·Application pending·0 cites
- 1773US2022387445A1Prostacyclin analogue formulationsCAMURUS AB·Filed 2022·Application pending·0 cites
- 1869US2021308226A1Controlled release peptide formulationsCAMURUS AB·Filed 2021·Application pending·0 cites
- 1966US11369617B2Prostacyclin analogue formulationsCAMURUS AB·Filed 2017·Granted Jun 28, 2022·0 cites·31 claims
- 2066US2019350841A1Lipid formulations comprising a thiolated antioxidantCAMURUS AB·Filed 2018·Application pending·0 cites
- 2165US11433120B2Controlled release peptide formulationsTIBERG FREDRIK·Filed 2012·Granted Sep 6, 2022·1 cites·28 claims
- 2263US2023285502A1Mixtures and formulationsCAMURUS AB·Filed 2023·Application pending·0 cites
- 2362US2019054177A1Peptide slow-release formulationsCAMURUS AB·Filed 2018·Application pending·0 cites
- 2461US2017281537A1Lipid formulations comprising a thiolated antioxidantCAMURUS AB·Filed 2017·Application pending·0 cites
- 2558US12246055B2Lipid-controlled release compositionsCAMURUS AB·Filed 2020·Granted Mar 11, 2025·0 cites·23 claims
- 2657US2018207089A1Acid containing lipid formulationsCAMURUS AB·Filed 2017·Application pending·0 cites
- 2757US2025325626A1Lipid-controlled release compositionsCAMURUS AB·Filed 2025·Application pending·0 cites
- 2853US2015366973A1Peptide slow-release formulationsCAMURUS AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Catalin Nistor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →